Log in
Enquire now
‌

US Patent 11207353 Immunocompatible amniotic membrane products

Patent 11207353 was granted and assigned to Osiris Therapeutics on December, 2021 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Osiris Therapeutics
Osiris Therapeutics
Current Assignee
Osiris Therapeutics
Osiris Therapeutics
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11207353
Patent Inventor Names
Timothy Jansen0
Jennifer Michelle Marconi0
Jin-Qiang Kuang0
Samson Tom0
Alla Danilkovitch0
Dana Yoo0
Date of Patent
December 28, 2021
Patent Application Number
16296475
Date Filed
March 8, 2019
Patent Primary Examiner
‌
L. Blaine Lankford
Patent abstract

Provided herein is a placental product comprising an immunocompatible amniotic membrane. Such placental products can be cryopreserved and contain viable therapeutic cells after thawing. The placental product of the present invention is useful in treating a patient with a tissue injury (e.g. wound or burn) by applying the placental product to the injury. Similar application is useful with ligament and tendon repair and for engraftment procedures such as bone engraftment.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11207353 Immunocompatible amniotic membrane products

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.